198 related articles for article (PubMed ID: 12087813)
1. Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms.
Flowers F
Int J Dermatol; 2002 May; 41 Suppl 1():12-5. PubMed ID: 12087813
[No Abstract] [Full Text] [Related]
2. Viral and nonviral uses of imiquimod: a review.
Gupta AK; Cherman AM; Tyring SK
J Cutan Med Surg; 2004; 8(5):338-52. PubMed ID: 15868314
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod 5 percent cream and the treatment of cutaneous malignancy.
Navi D; Huntley A
Dermatol Online J; 2004 Jul; 10(1):4. PubMed ID: 15347486
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod for superficial and in situ skin malignancy.
Drug Ther Bull; 2009 Oct; 47(10):113-6. PubMed ID: 19809085
[TBL] [Abstract][Full Text] [Related]
5. Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment.
Wolf IH; Kodama K; Cerroni L; Kerl H
Am J Dermatopathol; 2007 Jun; 29(3):237-41. PubMed ID: 17519620
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Bowen's disease with photodynamic therapy after Imiquimod: the need for controlled trials.
Vereecken P; Heenen M
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1397-9. PubMed ID: 17062104
[No Abstract] [Full Text] [Related]
7. [Treatment of Bowen's disease of the penis with imiquimod 5% cream].
de Diego Rodríguez E; Villanueva Peña A; Hernández Castrillo A; Gómez Ortega JM
Actas Urol Esp; 2005 Sep; 29(8):797-800. PubMed ID: 16304915
[TBL] [Abstract][Full Text] [Related]
8. [Imiquimod in the treatment of lentigo maligna].
Nagore E; Botella-Estrada R
Actas Dermosifiliogr; 2011 Oct; 102(8):559-62. PubMed ID: 21536245
[No Abstract] [Full Text] [Related]
9. Imiquimod treatment of lentigo maligna: an open-label study of 34 primary lesions in 32 patients.
Buettiker UV; Yawalkar NY; Braathen LR; Hunger RE
Arch Dermatol; 2008 Jul; 144(7):943-5. PubMed ID: 18645150
[No Abstract] [Full Text] [Related]
10. Treatment of lentigo maligna with topical imiquimod.
Naylor MF; Crowson N; Kuwahara R; Teague K; Garcia C; Mackinnis C; Haque R; Odom C; Jankey C; Cornelison RL
Br J Dermatol; 2003 Nov; 149 Suppl 66():66-70. PubMed ID: 14616356
[TBL] [Abstract][Full Text] [Related]
11. [Photodynamic therapy vs imiquimod].
Serra-Guillén C; Nagore E; Guillén C
Actas Dermosifiliogr; 2012; 103(6):488-501. PubMed ID: 22178262
[TBL] [Abstract][Full Text] [Related]
12. Topical treatment of lentigo maligna melanoma with imiquimod 5% cream.
Borucki U; Metze D
Dermatology; 2003; 207(3):326-8. PubMed ID: 14571081
[No Abstract] [Full Text] [Related]
13. Successful use of imiquimod 5% cream in Bowen's disease.
Prabhu S; Rao R; Sripathi H; Hameed S; Kuduva R
Indian J Dermatol Venereol Leprol; 2007; 73(6):423-5. PubMed ID: 18032866
[No Abstract] [Full Text] [Related]
14. Occlusive medication with imiquimod in Bowen's disease.
Muzio G; Ciambellotti A; Rebora A
Acta Derm Venereol; 2004; 84(2):168-9. PubMed ID: 15206706
[No Abstract] [Full Text] [Related]
15. Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod.
Wolf IH; Cerroni L; Kodama K; Kerl H
Arch Dermatol; 2005 Apr; 141(4):510-4. PubMed ID: 15837872
[TBL] [Abstract][Full Text] [Related]
16. Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream.
Chapman MS; Spencer SK; Brennick JB
Arch Dermatol; 2003 Jul; 139(7):943-4. PubMed ID: 12873902
[No Abstract] [Full Text] [Related]
17. Extensive lentigo maligna clearing with topical imiquimod.
Epstein E
Arch Dermatol; 2003 Jul; 139(7):944-5. PubMed ID: 12873903
[No Abstract] [Full Text] [Related]
18. [Topical imiquimod as palliative therapy for extensive lentigo maligna on the cheek].
Cheikhrouhou H; Pouaha J; Claeys A; Truchetet F
Ann Dermatol Venereol; 2010 Feb; 137(2):142-4. PubMed ID: 20171439
[No Abstract] [Full Text] [Related]
19. Treatment of Bowen's disease using a cycle regimen of imiquimod 5% cream.
Chen K; Shumack S
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():10-2. PubMed ID: 14616804
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Bowen's disease and erythroplasia of Queyrat.
Arlette JP
Br J Dermatol; 2003 Nov; 149 Suppl 66():43-9. PubMed ID: 14616349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
